{"schema_version":"alpha-profile-public-v1","slug":"ann-m-cunningham-mba","canonical_url":"https://registry.alpha.ac/people/ann-m-cunningham-mba","as_of":"2026-09-21T19:11:59.024327+00:00","published_at":"2026-09-02T02:37:23.804649+00:00","last_reviewed_at":"2026-05-16T03:19:46.525+00:00","identity":{"display_name":"Ann M. Cunningham, MBA","headshot_url":null,"headshot_media":null,"profile_kind":"director","role_tags":["director","executive"],"current_role":{"company_name":"Vistagen Therapeutics, Inc.","company_slug":"vistagen-therapeutics-inc","exchange":"NASDAQ","ticker":"VTGN","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":false,"valid_from":"2019-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1411685/000141168525000052/vtgn-20250728.htm","effective_date":"2025-07-28","last_checked_at":"2026-04-28T22:57:01.693+00:00"}},"photo_match":null},"assurance":{"is_claimed":false,"status":"unverified","assurance_level":null,"method":null,"verified_at":null,"expires_at":null},"claiming":{"eligible":true,"label":"Is this you? Claim your Alpha Profile","claim_url":"https://terminal.alpha.ac/claim-profile?person=ann-m-cunningham-mba","suggest_edit_label":"Suggest an edit","suggest_edit_url":"https://terminal.alpha.ac/claim-profile?person=ann-m-cunningham-mba&mode=suggest","canonical_record_will_be_reused":true,"canonical_facts_owner_controlled":false},"presentation":{"schema_version":"alpha-profile-presentation-v1","state":"alpha_editorial","version":0,"published_at":null,"headline":null,"headline_evidence":null,"location":null,"photo":null,"cover":null,"about":["Founder and Managing Partner of i3 Strategy Partners, a pharmaceutical consulting firm. Previously served as Chief Commercial Officer of Vistagen, Vice President at Teva Pharmaceuticals, and held multiple marketing positions at Otsuka Pharmaceutical and Eli Lilly. Holds MBA from University of Michigan with focus on marketing management."],"links":[],"sources":[],"featured":[],"competencies":[],"board_preferences":null,"board_service":[{"organization":"Vistagen Therapeutics, Inc.","organizationId":"vistagen-therapeutics-inc","title":"Director","period":"2019-01-01 · current","evidenceLabel":"sec_proxy","evidenceState":"verified","sourceUrl":"https://www.sec.gov/Archives/edgar/data/1411685/000141168525000052/vtgn-20250728.htm"}],"experience":[],"education":[],"credentials":[],"section_order":null,"hidden_sections":[],"limitations":["Presentation fields do not alter independently verified Alpha Profile facts.","Owner-supplied résumé records retain their field-level evidence state.","Only confirmed company_person_roles with public evidence. Website governed_site_fallback rows are not invented. about/links are stored people.profile_summary/bio and linkedin_url only. Dates stay undisclosed when the role has no start_date. SoFi Bank is not SoFi Technologies."]},"presentation_authority":"confirmed_company_person_roles","roles":[{"company_name":"Vistagen Therapeutics, Inc.","company_slug":"vistagen-therapeutics-inc","exchange":"NASDAQ","ticker":"VTGN","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":false,"valid_from":"2019-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1411685/000141168525000052/vtgn-20250728.htm","effective_date":"2025-07-28","last_checked_at":"2026-04-28T22:57:01.693+00:00"}}],"claims":[{"claim_type":"ai_ml_experience","claim_value":false,"claim_text":"Proxy extraction classified AI/ML experience for Ann M. Cunningham, MBA as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T03:19:46.693333+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"VTGN DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1411685/000141168525000052/vtgn-20250728.htm","published_at":"2025-07-28T00:00:00+00:00","last_checked_at":"2026-05-16T03:19:46.583634+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"board_role","claim_value":"Director","claim_text":"Ann M. Cunningham, MBA currently serves as Director at Vistagen Therapeutics, Inc..","claim_state":"verified","valid_from":"2025-07-28","valid_to":null,"confidence":0.92,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T03:19:46.650404+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"VTGN DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1411685/000141168525000052/vtgn-20250728.htm","published_at":"2025-07-28T00:00:00+00:00","last_checked_at":"2026-05-16T03:19:46.583634+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"committee_assignments","claim_value":[],"claim_text":"Ann M. Cunningham, MBA serves on no disclosed committees.","claim_state":"verified","valid_from":"2025-07-28","valid_to":null,"confidence":0.88,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T03:19:46.670685+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"VTGN DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1411685/000141168525000052/vtgn-20250728.htm","published_at":"2025-07-28T00:00:00+00:00","last_checked_at":"2026-05-16T03:19:46.583634+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"current_executive_company","claim_value":"i3 Strategy Partners","claim_text":"Ann M. Cunningham, MBA is linked to i3 Strategy Partners as an operating executive.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.85,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T00:43:24.466766+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"VTGN DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1411685/000141168525000052/vtgn-20250728.htm","published_at":"2025-07-28T00:00:00+00:00","last_checked_at":"2026-05-16T03:19:46.583634+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"current_executive_role","claim_value":"Founder and Managing Partner","claim_text":"Ann M. Cunningham, MBA is also listed as Founder and Managing Partner.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.85,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T00:43:24.45036+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"VTGN DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1411685/000141168525000052/vtgn-20250728.htm","published_at":"2025-07-28T00:00:00+00:00","last_checked_at":"2026-05-16T03:19:46.583634+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"cybersecurity_experience","claim_value":false,"claim_text":"Proxy extraction classified cybersecurity experience for Ann M. Cunningham, MBA as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T03:19:46.72588+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"VTGN DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1411685/000141168525000052/vtgn-20250728.htm","published_at":"2025-07-28T00:00:00+00:00","last_checked_at":"2026-05-16T03:19:46.583634+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"technology_background","claim_value":false,"claim_text":"Proxy extraction classified technology background for Ann M. Cunningham, MBA as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T03:19:46.710115+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"VTGN DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1411685/000141168525000052/vtgn-20250728.htm","published_at":"2025-07-28T00:00:00+00:00","last_checked_at":"2026-05-16T03:19:46.583634+00:00","relation":"supports","excerpt_locator":null}]},{"subject":"alpha:person:ann-m-cunningham-mba","claim_type":"board_service","claim_value":{"tags":[],"title":"Director","period":"2019-01-01 · current","organization":"Vistagen Therapeutics, Inc.","organization_id":"vistagen-therapeutics-inc"},"claim_text":"Director at Vistagen Therapeutics, Inc. (2019-01-01 · current)","valid_from":null,"valid_to":null,"verification_status":"confirmed","date_precision":"period_text_only","evidence":[{"source_url":"https://www.sec.gov/Archives/edgar/data/1411685/000141168525000052/vtgn-20250728.htm","label":"sec_proxy","evidence_state":"verified"}],"claim_state":"confirmed","version":1}],"network":{"schema_version":"alpha-profile-network-public-v1","relationships":[],"relationship_pathfinding":false,"authentication_prompt":"Sign in to see how you're connected.","limitations":["Representative factual associations only.","Shared contexts do not assert personal acquaintance.","Anonymous graph traversal is not available."]},"permissions":{"classification":"open_public_projection","public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false},"limitations":["Only permissioned public claims and evidence are included.","Absence of a claim is not evidence that the underlying fact is false.","Public retrieval does not grant model-training or redistribution rights.","Private relationships and Council activity are excluded."],"structured_data":{"@context":"https://schema.org","@type":"ProfilePage","@id":"https://registry.alpha.ac/people/ann-m-cunningham-mba#profile","url":"https://registry.alpha.ac/people/ann-m-cunningham-mba","dateModified":"2026-05-16T03:19:46.525+00:00","mainEntity":{"@type":"Person","@id":"https://registry.alpha.ac/people/ann-m-cunningham-mba#person","name":"Ann M. Cunningham, MBA","url":"https://registry.alpha.ac/people/ann-m-cunningham-mba","jobTitle":"Director","worksFor":{"@type":"Organization","name":"Vistagen Therapeutics, Inc.","tickerSymbol":"NASDAQ: VTGN"},"affiliation":[{"@type":"OrganizationRole","roleName":"Director","startDate":"2019-01-01","memberOf":{"@type":"Organization","name":"Vistagen Therapeutics, Inc.","url":"https://registry.alpha.ac/companies/vistagen-therapeutics-inc","tickerSymbol":"NASDAQ: VTGN"}}]},"isBasedOn":[{"@type":"CreativeWork","url":"https://www.sec.gov/Archives/edgar/data/1411685/000141168525000052/vtgn-20250728.htm","name":"VTGN DEF 14A director slate"}],"mainEntityOfPage":"https://registry.alpha.ac/people/ann-m-cunningham-mba"},"trust":{"schema_version":"alpha-profile-trust-v1","verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":9,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"aggregation":{"schema_version":"alpha-claim-aggregation-v1","published_claim_count":9,"under_review_claim_count":0,"owner_supplied_claim_count":0,"evidence_record_count":3,"distinct_source_count":1,"conflicts":[],"conflict_count":0,"headline_conflict_count":0,"internal_review_conflict_count":0,"contradiction_types":[],"headline_conflict_types":[],"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":9,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"coverage":{"schema_version":"alpha-coverage-metric-v1","published_claims":9,"corroborated_claims":0,"sources":3,"distinct_sources":1,"role_claims":1,"last_reviewed_at":"2026-05-16T03:19:46.525+00:00","observed_at":"2026-09-21T19:11:59.024327+00:00","freshness_days":129}},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"}},"projection":{"schema_version":"alpha-profile-projection-v5","entity":{"kind":"person","slug":"ann-m-cunningham-mba","canonical_url":"https://registry.alpha.ac/people/ann-m-cunningham-mba"},"publication":{"published_at":"2026-09-02T02:37:23.804649+00:00","last_reviewed_at":"2026-05-16T03:19:46.525+00:00","as_of":"2026-09-21T19:11:59.024327+00:00"},"representations":{"html":{"href":"https://registry.alpha.ac/people/ann-m-cunningham-mba","media_type":"text/html"},"json":{"href":"https://registry.alpha.ac/api/public/profiles/ann-m-cunningham-mba","media_type":"application/json"},"markdown":{"href":"https://registry.alpha.ac/people/ann-m-cunningham-mba.md","media_type":"text/markdown"},"structured_data":{"embedded":true,"media_type":"application/ld+json"},"share_image":null},"permissions":{"public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false}}}